COVID-19 Vaccine Roll Outs in ASEAN & Asia – Live Updates by Country

Posted by Written by Reading Time: 13 minutes

(This article will be updated continuously. It was originally published on January 28, 2020. It was last updated on May 14, 2021)

Details of COVID-19 availability in all ten ASEAN countries and another 30 Asian nations.

Due to the developing situation in China and Asia concerning the Coronavirus, we will be operating this article as a running live update service to keep businesses involved in ASEAN and Asia updated with the latest relevant regional news.

For specific updates concerning China and related business advisory, please click here.

ASEAN coronavirus updates (Live updates by country)

Brunei

Brunei has joined the global Covax scheme and is expecting to have the COVID-19 vaccine in Q1 2021, having sourced enough supplies to cover 50% of the population. Discussions are on-going with other suppliers.   

  • Brunei reported one new case on May 12, taking the total to 331 amid three deaths.
  • Brunei recorded one new case on May 8, bringing the total to 330 cases amid three deaths.
  • Brunei saw one new case on May 7, taking the total to 229 cases amid three deaths.

Cambodia

Cambodia is expected to import vaccines from both China and Russia. China’s vaccines are still undergoing clinical trials while Russia has already commenced production. Australia has offered financial support to aid vaccine coverage in several southeast Asia countries including Cambodia.  

  • Cambodia saw 446 new cases and six deaths on May 13, taking the totals to 21,141 cases and 142 deaths.
  • Cambodia recorded 472 new cases and five deaths on May 12, taking the totals to 20,695 cases and 136 deaths.
  • Cambodia saw 480 new cases and five deaths on May 11, bringing the tallies to 20,223 cases and 131 deaths.

Indonesia

Indonesia has commenced vaccinations with just over nine million doses being given to front line workers from last month. China’s Sinovac is in discussions with Indonesia to provide supplies, however, the Government faces difficulties with a large population of 268 million and price sensitivity at Sinovac’s estimated costs at 200,000 rupiah (US$20) a dose. Indonesia’s Health Ministry’s Disease Control and Prevention Director-General Achmad Yurianto said that vaccinations would only be provided to citizens aged 18-59. The vaccine has also been required to pass halal certification prior to use and it is uncertain how the country can source enough vaccines to reach a sizeable part of its population.  Australia has stated it will also provide financial support to solve these issues.  

  • Indonesia reported 3,448 new cases and 99 deaths on May 13, taking the tallies to 1,731,652 cases and 47,716 deaths.
  • Indonesia recorded 4,608 new cases and 152 deaths on May 12, taking the totals to 1,728,204 cases and 47,617 deaths.
  • Indonesia reported 5,021 new cases and 247 deaths on May 11, taking the tallies to 1,723,596 cases and 47,465 deaths.

Laos

Laos has been trialing the Russian Sputnik V vaccine and is also in discussions with China about acquiring supplies.  

  • Laos recorded 65 new cases on May 13, taking the total to 1,482 cases amid one death.
  • Laos saw 55 new cases on May 12, taking the total to 1,417 cases amid one death.
  • Laos reported 35 new cases on May 11, taking the total to 1,362 cases amid one death.

Malaysia

Malaysia is to provide vaccines free of charge to its nationals, but foreigners will need to pay for the treatment, according to the Malaysian Minister of Health, Tan Sri Muhyiddin Yassin, who has signed a deal with Pfizer for 12.8 million doses. These will be administered in two stages of 6.4 million people each, with the program to commence in Q1 2021. The country aims to inoculate between 80-100% of its citizens. 

  • Malaysia recorded 4,855 new cases and 27 deaths on May 13, taking the tallies to 458,077 cases and 1,788 deaths.
  • Malaysia reported 4,765 new cases and 39 deaths on May 12, taking the totals to 453,222 cases and 1,761 deaths.
  • Malaysia saw 3,973 new cases and 22 deaths on May 11, taking the tallies to 448,457 cases and 1,722 deaths.

Myanmar

Myanmar is seeking assistance from the Gavi and Covax programs to acquire vaccines, while Australia is also providing financial relief. At present, the Government aims to treat 20 percent of the ‘most at risk’ in the country with vaccines. The Government is struggling with finances and logistics and is also under US sanctions, while cases are surging. The Government has banned the celebration of Christmas and other seasonal celebrations.   

  • Myanmar saw seven new cases and one death on May 14, taking the totals to 143,004 cases and 3,212 deaths.
  • Myanmar reported seven new cases and two deaths on May 13, taking the total to 143,004 cases amid 3,211 deaths.
  • Myanmar recorded 23 new cases and one death on May 12, taking the total to 142,997 cases amid 3,210 deaths.

Philippines

The Philippines aims to commence vaccinations from June 2021 and expects to inoculate about 25 million people (about 25 percent of its population) over the course of the year. The country has been badly affected by the virus and has the second-highest rate in Southeast Asia. The business community has reacted, more than 30 local companies signed an agreement to purchase at least 2.6 million vaccine doses from AstraZeneca in the country’s first such deal to secure coronavirus vaccines, ten days ago. They plan to donate a large part of the doses to the government for its planned vaccination program and use the rest to inoculate their employees. 

  • The Philippines reported 6,385 new cases and 107 deaths on May 13, taking the tallies to 1,124,724 cases and 18,821 deaths.
  • The country reported 4,842 new cases and 94 deaths on May 12, bringing the totals to 1,118,359 cases and 18,714 deaths.
  • The Philippines saw 4,734 new cases and 59 deaths on May 11, taking the tallies to 1,113,547 cases and 18,620 deaths.

Singapore

Singapore has been working on producing its own ‘Lunar’ vaccine, in a joint venture between the US company Arcturus together with the Duke-NUS medical school. It is a single dose, mRNA shot, developed from genetically engineering COVID-19 genes into an otherwise harmless virus. This technique is marginally safer than other vaccines which rely on dead Covid-19 material to provoke an immune response. The vaccine is expected to be available from Q1 2021. High-risk personnel will receive the vaccine first in a process to be determined by the government.     

  • Singapore saw 31 new cases on May 13, taking the total to 61,453 cases amid 31 deaths.
  • Singapore reported 16 new cases on May 12, taking the total to 61,419 cases amid 31 deaths.
  • Singapore recorded 25 new cases on May 11, taking the total to 61,403 cases amid 31 deaths.

Thailand

Thailand is currently expecting vaccines to be delivered in mid-2021. The doses would cover 13 million people in a population of about 69 million. Thailand’s National Vaccine Institute signed a non-refundable advance market commitment contract worth 2.38 billion baht (US$79 million) with AstraZeneca to reserve the supplies. Discussions are also on-going with Oxford University in the UK to secure a vaccine that could be available in Q1 if trials are completed in time.   

  • Thailand reported 4,887 new cases and 32 deaths on May 13, taking the totals to 93,794 cases and 518 deaths.
  • Thailand saw 1,983 new cases and 34 deaths on May 12, taking the tallies to 88,907 cases and 486 deaths.
  • Thailand recorded 1,919 new cases and 31 deaths on May 11, taking the totals to 86,924 cases and 452 deaths.

Vietnam

Vietnam’s National Institute of Hygiene and Epidemiology (NIHE), a division of Vietnam’s Ministry of Health, has signed an agreement with Medigen Vaccine, a Taipei, Taiwan-based vaccine company to secure the supply of 3 million to 10 million COVID-19 vaccine doses in 2021. Medigen is currently conducting Phase II studies of the vaccine, co-developed with the USA’s National Institutes of Health (NIH), in Taiwan and Vietnam with a view to a Q1 2021 rollout.  

Vietnam is also working on producing its own vaccine, with the Institute of Vaccines and Medical Biologicals (IVAC) in Nha Trang City, partnering with New York City-based Icahn School of Medicine and the global health non-profit organization PATH. Phase 1 trials are already underway in Vietnam, while Phases 2 & 3 will be conducted at the beginning of 2021. The institute plans to submit documents for approval to the health ministry as early as April next year and claims to be capable of producing 30 million doses a year, expecting that a national vaccine could be distributed to the general population in October 2021.

  • Vietnam reported 87 new cases on May 13, taking the total to 3,710 amid 35 deaths.
  • As of May 12, 2021, Vietnam’s Ministry of Health confirmed a total of 3,623 cases of COVID-19. However, 2,618 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 35 deaths due to the pandemic. The latest community transmission cases have been reported from Hanoi, Vinh Phuc, Da Nang, Bac Giang, and Lang Son among others.
  • As of May 11, 2021, Vietnam’s Ministry of Health confirmed a total of 3,507 cases of COVID-19. However, 2,618 of the affected patients have recovered and been discharged from hospitals. Vietnam has also recorded 35 deaths due to the pandemic. The latest community transmission cases have been reported from Bac Ninh, Vinh Phuc, Bac Giang, Lang Son, and Hai Duong.

Other Asian countries and Regions

Afghanistan

Afghanistan faces two pandemics at the same time, Covid-19 and Polio. UNICEF is currently embarking on an urgent Polio vaccination program while the country is in talks with both China and Russia oversupplying COVID-19 vaccines. Government-imposed lockdowns increased conflict with the Taliban, and an overall lack of awareness of the disease has prevented many Afghani’s from obtaining treatment of either. 

  • Afghanistan has 63,349 cases and 2,730 deaths as of May 13.
  • As of May 12, Afghanistan has 62,942 cases and 2,721 deaths.
  • Afghanistan has 62,718 cases and 2,713 deaths as of May 11.

Bangladesh

Bangladesh will receive 68 million doses of the COVID-19 vaccine from Gavi, which is committed to ensuring at least 20 percent of populations are inoculated. Each complete dose will cost about 200 Taka (US$2). The country is also in discussions with India concerning a further 30 million doses from the Serum Institute at about 450 Taka (US$5). Vaccinations are expected to commence in Q1 2021.     

  • Bangladesh has 778,687 cases and 12,076 deaths as of May 13.
  • As of May 12, Bangladesh has 777,397 cases and 12,045 deaths.
  • As of May 11, Bangladesh has 776,257 cases and 12,005 deaths.

Bahrain

Bahrain has begun COVID-19 vaccinations for front line personnel using a joint Chinese-UAE Sinopharm product. Roll out among the general population is expected in Q1 2021.  

  • Bahrain has 196,105 cases and 715 deaths as of May 13.
  • Bahrain has 194,289 cases and 705 deaths as of May 12.
  • As of May 11, Bahrain has 192,750 cases and 697 deaths.

China

For specific updates concerning China, please click here.

For a complete overview of China’s vaccine availability please go here.

  • China reported seven new cases on May 14, taking the total to 90,815.
  • China saw nine new cases on May 13, taking the total to 90,808.
  • China recorded 16 new cases on May 12, taking the total to 90,799.

East Timor

East Timor is receiving assistance from the Gavi Institute.  

  • As of May 13, East Timor has 3,879 cases and eight deaths.
  • East Timor has 3,626 cases and five deaths as of May 12.
  • As of May 11, East Timor has 3,493 cases and five deaths.

Hong Kong

Hong Kong will provide COVID-19 vaccines free to all residents, with a vaccine being delivered in stages. The government has said it may take most of 2021 to reach 100 percent coverage for all citizens.  

  • Hong Kong has 11,818 cases and 210 deaths as of May 13.
  • Hong Kong has 11,815 cases and 210 deaths as of May 12.
  • Hong Kong has 11,813 cases and 210 deaths as of May 11.

India

For a complete overview of India’s vaccine availability please go here.

  • India has 24,046,120 cases and 262,350 deaths as of May 13.
  • As of May 12, India has 23,702,832 cases and 258,351 deaths.
  • Our new India-specific updates can be found here.

Iran

Iran is jointly producing a COVID-19 vaccine with Russia, and the product has entered trials. National inoculation is expected to commence in September 2021.   

  • Iran has 2,722,007 cases and 76,231 deaths as of May 13.
  • As of May 12, Iran has 2,707,761 cases and 75,934 deaths.
  • Iran has 2,691,352 cases and 75,568 deaths as of May 11.

Iraq

Iraq is currently in discussions with US company Pfizer concerning supplies of a COVID-19 vaccine. Supplies are expected in Q2 2021. 

  • Iraq has 1,132,092 cases and 15,883 deaths as of May 13.
  • Iraq has 1,127,580 cases and 15,855 deaths as of May 12.
  • As of May 11, Iraq has 1,122,914 cases and 15,834 deaths.

Japan

Japan is sourcing 145 million doses of vaccine from the United States and the UK and will be delivering them free of charge to all citizens commencing Q1 2021. 

  • Japan has 658,629 cases and 11,165 deaths as of May 13.
  • As of May 12, Japan has 651,702 cases and 11,064 deaths.
  • Japan has 645,817 cases and 10,941 deaths as of May 11.

Jordan

Jordan is sourcing vaccines from Pfizer and expects to commence vaccinations from Q1 2021. 

  • Jordan has 722,754 cases and 9,203 deaths as of May 13.
  • Jordan has 722,336 cases and 9,180 deaths as of May 12.
  • As of May 11, Jordan has 721,853 cases and 9,151 deaths.

Kazakhstan

Kazakhstan has been developing its own vaccines with ‘Quazcovid’ being admitted by the WHO as a safe candidate. These are currently undergoing trials with a roll out expected in Q2 2021.  

  • Kazakhstan has 350,591 cases and 3,984 deaths as of May 13.
  • As of May 12, Kazakhstan has 348,308 cases and 3,964 deaths.
  • Kazakhstan has 346,497 cases and 3,948 deaths as of May 11.

Kuwait

All citizens, including expatriates, will receive COVID-19 vaccines for free. Kuwait is importing one million vaccines from Pfizer, 1.7 million from Moderna, and three million doses of the Oxford-AstraZeneca vaccines and will commence a nationwide program from January.

  • Kuwait has 289,243 cases and 1,674 deaths as of May 13.
  • Kuwait has 288,184 cases and 1,669 deaths as of May 12.
  • As of May 11, Kuwait has 287,199 cases and 1,660 deaths.

Kyrgyzstan

Kyrgyzstan is sourcing vaccines from Russia with the Sputnik V vaccine expected to be rolled out in Q2 2021. 

  • Kyrgyzstan has 99,645 cases and 1,681 deaths as of May 13.
  • As of May 12, Kyrgyzstan has 99,316 cases and 1,675 deaths.
  • As of May 11, Kyrgyzstan has 99,033 cases and 1,667 deaths.

Lebanon

Lebanon is sourcing vaccines from Pfizer and is expected to take deliveries from mid-February 2021.  

  • Lebanon has 534,968 cases and 7,569 deaths as of May 13.
  • Lebanon has 534,388 cases and 7,549 deaths as of May 12.
  • As of May 11, Lebanon has 533,685 cases and 7,527 deaths.

Macao

Macao is part of the Covax scheme and is expected to receive 1.4 million doses of vaccine. The product will cost Pataca 300 (US$40). Roll out is expected in late Q1 2021.   

  • As of April 10, Macao has 49 cases.
  • Macao has 48 cases as of February 5.
  • The number of cases has reached 45 as of July 24.

Maldives

The Maldives will receive vaccines under the Covax program and will receive enough products to reach 20 percent of its population. Roll out is expected in Q2 2021.  

  • As of May 13, the Maldives has 41,308 cases and 87 deaths.
  • The Maldives has 40,092 cases and 87 deaths as of May 12.
  • The Maldives has 38,520 cases and 87 deaths as of May 11.

Mongolia

Mongolia is in discussions with Astra-Zeneca to purchase COVID-19 vaccines and is also part of the Covax scheme. Roll out is expected in Q2 2021. 

  • Mongolia has 47,033 cases and 193 deaths as of May 13.
  • Mongolia has 46,448 cases and 184 deaths as of May 12.
  • As of May 11, Mongolia has 45,936 cases and 179 deaths.

Nepal

Nepal will source COVID-19 vaccines under the Covax program and will also purchase supplies from India. The rollout is expected from Q2 2021.  

  • Nepal has 431,191 cases and 4,466 deaths as of May 13.
  • Nepal has 422,349 cases and 4,252 deaths as of May 12.
  • As of May 11, Nepal has 413,111 cases and 4,084 deaths.

North Korea

North Korea is expected to receive Covid-19 vaccines from China, with rumors that North Korean Leader Kim Jong-Un has already received treatment as part of medical trials.  

  • North Korea has reported its first case on July 25, the city of Kaesong is under lockdown.

Oman

Oman has sourced COVID-19 vaccines from Gavi and is buying additional supplies from Astra-Zeneca and Pfizer. Roll out will commence from January 2021 with each shot costing 10 Rial (US$24).    

  • As of May 11, Oman has 202,713 cases and 2,148 deaths.
  • Oman has 202,137 cases and 2,138 deaths as of May 10.
  • Oman has 201,350 cases and 2,120 deaths as of May 9.

Pakistan

Pakistan is also suffering from a Polio epidemic and is struggling with dealing with both. However, it has stated it will provide the vaccine for free with national inoculations to start from April 2021. 

  • Pakistan has 870,703 cases and 19,336 deaths as of May 13.
  • Pakistan has 867,438 cases and 19,210 deaths as of May 12.
  • As of May 11, Pakistan has 864,557 cases and 19,106 deaths.

Palestine

Israel is currently negotiating with the UAE to provide 1.5 million doses of vaccine to Palestine. The product is expected to be the Russian Sputnik V treatment and should be available to Palestinians in Q2 2021.   

  • Palestine has 303,270 cases and 3,401 deaths as of May 12.
  • Palestine has 302,777 cases and 3,393 deaths as of May 11.
  • As of May 10, Palestine has 302,249 cases and 3,378 deaths.

Qatar

Qatar has signed an agreement with Moderna to provide Covid-19 vaccines and has also signed deals with Pfizer and BioNTech. These will be made available from late Q1 2021. 

  • Qatar has 212,423 cases and 522 deaths as of May 13.
  • As of May 12, Qatar has 212,124 cases and 519 deaths.
  • Qatar has 211,732 cases and 516 deaths as of May 11.

Russia

A complete overview of the availability and production of Russian Covid-19 vaccines and costs can be found here.

  • Russia has 4,913,439 cases and 114,723 deaths as of May 13.
  • As of May 12, Russia has 4,905,059 cases and 114,331 deaths.
  • Our new Russia-specific updates here.

Saudi Arabia

Saudi Pharmaceutical Industries and Medical Appliances Corp. (SPIMACO) said last week that it had signed an agreement with the German biopharmaceutical company CureVac to provide Covid-19 vaccine. It plans to cover 70 percent of its population by the end of 2021 with treatment being available for free. The initial roll out is expected to be at the end of Q1 2021. 

  • Saudi Arabia has 430,505 cases and 7,122 deaths as of May 13.
  • As of May 12, Saudi Arabia has 429,389 cases and 7,111 deaths.
  • Saudi Arabia has 428,369 cases and 7,098 deaths as of May 11.

South Korea

South Korea has reached a deal with AstraZeneca to purchase its coronavirus vaccine candidate and is in final talks with global drug-makers including AstraZeneca, Pfizer Inc, and Johnson & Johnson over their vaccines. It launched a preliminary review of AstraZeneca’s product in October for potential fast-track approval. Roll out is expected in Q1 2021. 

  • South Korea has 130,380 cases and 1,893 deaths as of May 14.
  • South Korea has 129,633 cases and 1,891 deaths as of May 13.
  • As of May 12, South Korea has 128,918 cases and 1,884 deaths.

Sri Lanka

Sri Lanka is to receive 4.2 million doses of the COVID-19 vaccine from Gavi, enough to cover 20 percent of the population. It has not yet released information on when these will be made available.    

  • Sri Lanka has 135,796 cases and 868 deaths as of May 13.
  • As of May 12, Sri Lanka has 132,527 cases and 868 deaths.
  • Sri Lanka has 131,098 cases and 850 deaths as of May 11.

Taiwan

Taiwan has been developing its own vaccine and is also part of the Covax scheme. It has stated it will be able to manufacture enough of its own product for 50 percent population coverage with roll-out expected in Q1 2021.  

  • Taiwan has 1,256 cases and 12 deaths as of May 13.
  • Taiwan has 1,231 cases and 12 deaths as of May 12.
  • As of May 11, Taiwan has 1,210 cases and 12 deaths.

Turkey

Turkey has purchased 50 million doses of China’s Cornavac, manufactured by Sinopharm. These will be made available for free to the most at-risk population, inoculations start on December 11. Other treatments will be purchased and made available via medical outlets during the year and sold at cost price, and are likely to include products from Pfizer and Russia.   

  • Turkey has 5,083,996 cases and 44,059 deaths as of May 13.
  • Turkey has 5,072,462 cases and 43,821 deaths as of May 12.
  • As of May 11, Turkey has 5,059,433 cases and 43,589 deaths.

United Arab Emirates

The UAE is expected to authorize the use of China’s Sinopharm vaccine which is nearing the end of its clinical trials in the Emirates.  The UAE’s Prime Minister, Sheikh Mohammed bin Rashid Al Maktoum was inoculated as part of the testing. Roll out is expected in Q1 2021. The UAE is also manufacturing the vaccine and hopes to produce between 75-100 million doses during the year.  

  • The UAE has 542,158 cases and 1,623 deaths as of May 13.
  • The UAE has 540,646 cases and 1,619 deaths as of May 12.
  • The UAE has 539,138 cases and 1,617 deaths as of May 11.

Uzbekistan

Uzbekistan has been trailing China’s Anhui Zhifei Longcom Biopharmaceutical vaccine in addition to vaccines made by China’s Sinopharm and Russia’s Sputnik V. Roll out is expected in Q1 2021. 

  • Uzbekistan has 95,826 cases and 667 deaths as of May 13.
  • Uzbekistan has 95,467 cases and 666 deaths as of May 12.
  • As of May 11, Uzbekistan has 95,072 cases and 664 deaths.

Yemen

Yemen is suffering from war and diseases such as diphtheria, while local politicians have made wild claims that the country will develop its own COVID-19 vaccine. It is a member of the Gavi program and relief is likely to come from humanitarian sources.   

  • Yemen has 6,507 cases and 1,278 deaths as of May 13.
  • As of May 12, Yemen has 6,498 cases and 1,277 deaths.
  • Yemen has 6,492 cases and 1,276 deaths as of May 11.

Related Reading


About Us

ASEAN Briefing is produced by Dezan Shira & Associates. The firm assists foreign investors throughout Asia and maintains offices throughout ASEAN, including in SingaporeHanoiHo Chi Minh City, and Da Nang in Vietnam, Munich, and Esen in Germany, Boston, and Salt Lake City in the United States, Milan, Conegliano, and Udine in Italy, in addition to Jakarta, and Batam in Indonesia. We also have partner firms in Malaysia, Bangladesh, the Philippines, and Thailand as well as our practices in China and India. Please contact us at asia@dezshira.com or visit our website at www.dezshira.com.